1μg (R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
Species | Human |
Synonyms | CD360, NILR |
Accession | Q9HBE5-1 |
Amino Acid Sequence | Cys20-Pro236 with hIgG1 Fc at the C-terminus |
Expression System | HEK293 |
Molecular Weight | 65-75kDa (Reducing) |
Purity | >95% by SDS-PAGE & >90% by SEC-HPLC |
Conjugation | Unconjugated |
Tag | Human IgG1 Fc |
Physical Appearance | Lyophilized Powder |
Storage Buffer | PBS PH7.4 , 5% trehalose |
Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. |
Reference | Ren Y, Xue M, Hui X, Liu X, Farooq MA, Chen Y, Ji Y, Duan Y, Ajmal I, Yao J, Jiang W. Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer. Pharmacol Res. 2025 Feb;212:107637. |
Background
Human interleukin-21 receptor (IL21R), also known as CD360 or NILR, is a type I cytokine receptor belonging to the type 4 subfamily. It contains two fibronectin type-III domains and is selectively expressed in lymphoid tissues, with the highest expression in the thymus and spleen. IL21R is crucial for the proliferation and differentiation of T cells, B cells, and natural killer (NK) cells, as it transduces the growth-promoting signals of interleukin-21 (IL-21).
Picture
Picture
SDS-PAGE
SEC-HPLC
The purity of IL-21R Fc Chimera Protein, Human is more than 90% determined by SEC-HPLC.
ELISA
Immobilized IL-21 Protein, Human (Cat. No. UA040009) at 5.0μg/mL (100μL/well) can bind IL-21R Fc Chimera Protein, Human (Cat. No. UA011187) with EC50 of 15.71-18.64ng/mL.
